![](/img/cover-not-exists.png)
Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma
Decaudin, Didier, Frisch Dit Leitz, Estelle, Nemati, Fariba, Tarin, Malcy, Naguez, Adnan, Zerara, Mohamed, Marande, Benjamin, Vivet-Noguer, Raquel, Halilovic, Ensar, Fabre, Claire, Jochemsen, Aart, RoVolume:
126
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2019.12.012
Date:
February, 2020
File:
PDF, 2.56 MB
2020